![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Transgene Sa | LSE:0OCQ | London | Ordinary Share | FR0005175080 | TRANSGENE ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 7.9M | -22.33M | -0.2214 | -4.79 | 306.59M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 3.04 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
22/7/2024 | 07:00 | UKREG | Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at.. |
22/7/2024 | 07:00 | UKREG | Transgene et BioInvent présentent un poster sur le virus oncolytique.. |
10/7/2024 | 17:00 | UKREG | Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 30.. |
10/7/2024 | 17:00 | UKREG | Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of.. |
18/3/2024 | 16:45 | UKREG | Transgene Announces Upcoming Investor Meetings |
18/3/2024 | 16:45 | UKREG | Transgene annonce ses prochaines rencontres avec les investisseurs |
06/3/2024 | 06:30 | UKREG | Transgene présentera de nouvelles données sur son vaccin individualisé.. |
06/3/2024 | 06:30 | UKREG | Transgene to Present New Data on TG4050, an Individualized Cancer Vaccine,.. |
05/3/2024 | 06:30 | UKREG | Transgene, NEC et BostonGene étendent leur collaboration dans le cadre de.. |
05/3/2024 | 06:30 | UKREG | Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical.. |
Transgene (0OCQ) Share Charts1 Year Transgene Chart |
|
1 Month Transgene Chart |
Intraday Transgene Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions